{"schema_version":"secwatch.filing_event.v1","accession":"0001787306-23-000109","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.241776+00:00","generated_at":"2026-06-10T08:13:08.784175+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Arcutis appoints L. Todd Edwards as Chief Commercial Officer; Ayisha Jeter promoted","bullets":["Edwards joins from Incyte with 25+ years in dermatology/immunology at UCB and AbbVie.","He will lead ZORYVE cream launch for plaque psoriasis and prepare for future indications.","Ayisha Jeter promoted to SVP Marketing and Market Access, reporting to Edwards.","Edwards receives $500,016 base salary, 45% target bonus, equity grants of 240K options, 60K RSUs, 60K PSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001787306-23-000109","json":"https://secwatch.observer/filing/0001787306-23-000109.json","markdown":"https://secwatch.observer/filing/0001787306-23-000109.md","text":"https://secwatch.observer/filing/0001787306-23-000109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/arqt-20230927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:13:08.784175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be87147c96","claim":"L. Todd Edwards was appointed as Chief Commercial Officer at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"On September 27, 2023, Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) announced the appointment of L. Todd Edwards as the Company’s Chief Commercial Officer, effective as of September 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"},{"claim_id":"ddf06ace9a","claim":"Ayisha Jeter changed role as Senior Vice President, Marketing and Market Access at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"In connection with the appointment of Mr. Edwards, Ms. Jeter will be promoted to Senior Vice President, Marketing and Market Access, effective as of September 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Senior Vice President, Marketing and Market Access"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}